ONLINE SUBMISSION LOGIN

Psychiatry & Clinical Psychopharmacology formerly Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology

Editorial Manager ® for Psychiatry and Clinical Psychopharmacology

ANNOUNCEMENTS

ABSTRACT




Thomas R, Cetin M, Baker GB, Dursun SM.

Comment on FDA’s breakthrough therapy designation of intranasal esketamine for the treatment of major depressive disorder with imminent risk of suicide

doi: 10.5455/bcp.20161027122045



Keywords :

Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):329-31